The prognostic nomogram showed promising prediction efficacy and is expected to predict the prognosis of "driver-gene-negative" LUAD. The easy-to-use nomogram and the enriched pathways can help clinical decision-making, guide follow-up planning, and develop new therapeutic targets.
Shan et al. (Wed,) studied this question.